Cyclooxygenase-2 expression during immortalization and breast cancer progression

Xiangshan Zhao, Monica Goswami, Nidhi Pokhriyal, Hui Ma, Hongyan Du, Jun Yao, Thomas A. Victor, Kornelia Polyak, Charles D. Sturgis, Hamid Band, Vimla Band

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Identification of molecular aberrations in premalignant human mammary epithelial cells (hMEC), the precursors for breast cancers, is a central goal in breast cancer biology. Recent studies implicated expression of cyclooxygenase 2 (COX-2) as a marker to identify precursor cells for breast cancer. In this study, we analyzed COX-2 expression in preselection and postselection hMEC cells and observed similar COX-2 levels in both cells. Interestingly, immortalization of postselection cells using various methods leads to a dramatic decrease in COX-2 expression. Similar to immortal cells, the majority of breast cancer cell lines expressed low levels of COX-2 protein. Finally, analyses of COX-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in situ, and infiltrating ductal carcinoma showed down-regulation of COX-2 expression during tumor progression. Importantly, down-regulation of COX-2 using small interfering RNA in cells showed no effect on cell proliferation, anchorage-independent growth, migration, or invasion. These results show that (a) COX-2 overexpression does not seem to predict a breast cancer precursor cell and does not provide advantage for the cell to be transformed; (b) inhibition of COX-2 does not affect hMEC growth and oncogenic behavior in the conditions analyzed; and (c) COX-2 expression is decreased in breast cancer cell lines and cancer specimens as compared with normal mammary epithelial cells.

Original languageEnglish (US)
Pages (from-to)467-475
Number of pages9
JournalCancer Research
Volume68
Issue number2
DOIs
StatePublished - Jan 15 2008

Fingerprint

Cyclooxygenase 2
Breast Neoplasms
Breast
Epithelial Cells
Down-Regulation
Cell Line
Ductal Carcinoma
Carcinoma, Intraductal, Noninfiltrating
Mammaplasty
Growth
Small Interfering RNA
Neoplasms
Cell Proliferation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cyclooxygenase-2 expression during immortalization and breast cancer progression. / Zhao, Xiangshan; Goswami, Monica; Pokhriyal, Nidhi; Ma, Hui; Du, Hongyan; Yao, Jun; Victor, Thomas A.; Polyak, Kornelia; Sturgis, Charles D.; Band, Hamid; Band, Vimla.

In: Cancer Research, Vol. 68, No. 2, 15.01.2008, p. 467-475.

Research output: Contribution to journalArticle

Zhao, X, Goswami, M, Pokhriyal, N, Ma, H, Du, H, Yao, J, Victor, TA, Polyak, K, Sturgis, CD, Band, H & Band, V 2008, 'Cyclooxygenase-2 expression during immortalization and breast cancer progression', Cancer Research, vol. 68, no. 2, pp. 467-475. https://doi.org/10.1158/0008-5472.CAN-07-0782
Zhao, Xiangshan ; Goswami, Monica ; Pokhriyal, Nidhi ; Ma, Hui ; Du, Hongyan ; Yao, Jun ; Victor, Thomas A. ; Polyak, Kornelia ; Sturgis, Charles D. ; Band, Hamid ; Band, Vimla. / Cyclooxygenase-2 expression during immortalization and breast cancer progression. In: Cancer Research. 2008 ; Vol. 68, No. 2. pp. 467-475.
@article{662b2362a4744dd5b55a1faf95e1a3b2,
title = "Cyclooxygenase-2 expression during immortalization and breast cancer progression",
abstract = "Identification of molecular aberrations in premalignant human mammary epithelial cells (hMEC), the precursors for breast cancers, is a central goal in breast cancer biology. Recent studies implicated expression of cyclooxygenase 2 (COX-2) as a marker to identify precursor cells for breast cancer. In this study, we analyzed COX-2 expression in preselection and postselection hMEC cells and observed similar COX-2 levels in both cells. Interestingly, immortalization of postselection cells using various methods leads to a dramatic decrease in COX-2 expression. Similar to immortal cells, the majority of breast cancer cell lines expressed low levels of COX-2 protein. Finally, analyses of COX-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in situ, and infiltrating ductal carcinoma showed down-regulation of COX-2 expression during tumor progression. Importantly, down-regulation of COX-2 using small interfering RNA in cells showed no effect on cell proliferation, anchorage-independent growth, migration, or invasion. These results show that (a) COX-2 overexpression does not seem to predict a breast cancer precursor cell and does not provide advantage for the cell to be transformed; (b) inhibition of COX-2 does not affect hMEC growth and oncogenic behavior in the conditions analyzed; and (c) COX-2 expression is decreased in breast cancer cell lines and cancer specimens as compared with normal mammary epithelial cells.",
author = "Xiangshan Zhao and Monica Goswami and Nidhi Pokhriyal and Hui Ma and Hongyan Du and Jun Yao and Victor, {Thomas A.} and Kornelia Polyak and Sturgis, {Charles D.} and Hamid Band and Vimla Band",
year = "2008",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-07-0782",
language = "English (US)",
volume = "68",
pages = "467--475",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Cyclooxygenase-2 expression during immortalization and breast cancer progression

AU - Zhao, Xiangshan

AU - Goswami, Monica

AU - Pokhriyal, Nidhi

AU - Ma, Hui

AU - Du, Hongyan

AU - Yao, Jun

AU - Victor, Thomas A.

AU - Polyak, Kornelia

AU - Sturgis, Charles D.

AU - Band, Hamid

AU - Band, Vimla

PY - 2008/1/15

Y1 - 2008/1/15

N2 - Identification of molecular aberrations in premalignant human mammary epithelial cells (hMEC), the precursors for breast cancers, is a central goal in breast cancer biology. Recent studies implicated expression of cyclooxygenase 2 (COX-2) as a marker to identify precursor cells for breast cancer. In this study, we analyzed COX-2 expression in preselection and postselection hMEC cells and observed similar COX-2 levels in both cells. Interestingly, immortalization of postselection cells using various methods leads to a dramatic decrease in COX-2 expression. Similar to immortal cells, the majority of breast cancer cell lines expressed low levels of COX-2 protein. Finally, analyses of COX-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in situ, and infiltrating ductal carcinoma showed down-regulation of COX-2 expression during tumor progression. Importantly, down-regulation of COX-2 using small interfering RNA in cells showed no effect on cell proliferation, anchorage-independent growth, migration, or invasion. These results show that (a) COX-2 overexpression does not seem to predict a breast cancer precursor cell and does not provide advantage for the cell to be transformed; (b) inhibition of COX-2 does not affect hMEC growth and oncogenic behavior in the conditions analyzed; and (c) COX-2 expression is decreased in breast cancer cell lines and cancer specimens as compared with normal mammary epithelial cells.

AB - Identification of molecular aberrations in premalignant human mammary epithelial cells (hMEC), the precursors for breast cancers, is a central goal in breast cancer biology. Recent studies implicated expression of cyclooxygenase 2 (COX-2) as a marker to identify precursor cells for breast cancer. In this study, we analyzed COX-2 expression in preselection and postselection hMEC cells and observed similar COX-2 levels in both cells. Interestingly, immortalization of postselection cells using various methods leads to a dramatic decrease in COX-2 expression. Similar to immortal cells, the majority of breast cancer cell lines expressed low levels of COX-2 protein. Finally, analyses of COX-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in situ, and infiltrating ductal carcinoma showed down-regulation of COX-2 expression during tumor progression. Importantly, down-regulation of COX-2 using small interfering RNA in cells showed no effect on cell proliferation, anchorage-independent growth, migration, or invasion. These results show that (a) COX-2 overexpression does not seem to predict a breast cancer precursor cell and does not provide advantage for the cell to be transformed; (b) inhibition of COX-2 does not affect hMEC growth and oncogenic behavior in the conditions analyzed; and (c) COX-2 expression is decreased in breast cancer cell lines and cancer specimens as compared with normal mammary epithelial cells.

UR - http://www.scopus.com/inward/record.url?scp=39049146231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049146231&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-0782

DO - 10.1158/0008-5472.CAN-07-0782

M3 - Article

VL - 68

SP - 467

EP - 475

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 2

ER -